Skip to main content
. 2016 Jun 13;18:137. doi: 10.1186/s13075-016-1041-y

Table 4.

Background data in 24 patients with fibromyalgia (FMS) and 27 healthy controls (CON) obtained from questionnaires and clinical examination, and significance level (P value) for group comparison (Mann-Whitney U test)

Variables FMS CON P value
Age (years 57.0 (9.0) 57.0 (9.0) 0.800
Height (m) 1.65 (9.8) 1.65 (6.0) 0.743
Weight (kg) 68 (15) 63 (13) 0.091
BMI (kg/m2) 25.4 (6.6) 23.5 (4.5) 0.053
BP diastolic (mm Hg) 85 (10) 82.1 (8.3) 0.555
BP systolic (mm Hg) 133 (24) 131 (16) 0.494
Pain duration (years) 15.2 (8.2) NA
VAS overall (0–100) 52 (39) 0 (2) <0.001
Tender points (n) 15.9 (1.4) NA
PPT-all sites (kPa) 180 (112) 326 (100) <0.001
HAD-Depression (0–21) 6.0 (5.6) 1.6 (1.8) <0.001
HAD-Anxiety (0–21) 6.0 (7.0) 3.4 (3.1) 0.012
SF36-PSC (0–100) 30.0 (9.3) 54.4 (4.5) <0.001
SF36-MSC (0–100) 44.7 (18.5) 51.2 (6.0) 0.019

Data are presented as median (interquartile range)

Bold italic figures denote significant differences

BMI body mass index, BP blood pressure, HADS-Anxiety Hospital Anxiety and Depression Scale—anxiety subscale, HADS-Depression Hospital Anxiety and Depression Scale—depression subscale, NA not applicable, PPT-all sites pressure pain thresholds (mean for all sites), SF36-PCS Short-Form Health Survey 36-physical summary component, SF36-MSC Short-Form Health Survey 36-mental (psychological) summary component, VAS visual analogue scale